<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Musculoskeletal Disorders - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcmusculoskeletdisord/</link>
		<description>The latest articles from BMC Musculoskeletal Disorders (ISSN 1471-2474) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/66"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/65"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/64"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/63"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/62"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/61"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/60"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/59"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/58"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/57"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/56"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/9/55"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/66">
            
            <title>Percutaneous acetabuloplasty for metastatic acetabular lesions</title>
			<description>Background:
Osteolytic metastases around the acetabulum are frequent in tumour patients, and may cause intense and drug-resistant pain of the hip. These lesions also cause structural weakening of the pelvis, limping, and poor quality of life. Percutaneous acetabuloplasty is a mini-invasive procedure for the management of metastatic lesions due to carcinoma of the acetabulum performed in patients who cannot tolerate major surgery, or in patients towards whom radiotherapy had already proved ineffective. 
Methods:
We report a retrospective study in 25 such patients (30 acetabuli) who were evaluated before and after percutaneous acetabuloplasty, with regard to pain, mobility of the hip joint, use of analgesics, by means of evaluation forms: Visual Analog Scale, Harris Hip Score, Western Ontario and McMaster Universities Index of Osteoarthritis (WOMAC), Eastern Cooperative Oncology Group (ECOG). The results obtained were analysed using the chi 2 Test and Fisher's exact test. Significance was sent at P &lt; 0.05.
Results:
Marked clinical improvement was observed in all patients during the first six post-operative months, with gradual a worsening thereafter from deterioration of their general condition. 
Complete pain relief was achieved in 15 of our 25 (59%) of patients, and pain reduction was achieved in the remaining 10 (41%) patients. The mean duration of pain relief was 7.3 months. Pain recurred in three patients (12%) between 2 weeks to 3 months. No major complications occurred. There was transient local pain in most cases, and two cases of venous injection of cement without clinical consequences.
Conclusions:
Percutaneous acetabuloplasty is effective in improving the quality of life of patients with osteolytic bone tumours, even though the improvement is observed during the first six months only. It can be an effective aid to chemo- and radiotherapy in the management of acetabular metastases.</description>
			<link>http://www.biomedcentral.com/1471-2474/9/66</link>
			
			 	<dc:creator>Giulio Maccauro, Francesco Liuzza, Laura Scaramuzzo, Alessandro Milani, Francesco Muratori, Barbara Rossi, Victor Waide, Giandomenico Logroscino, Carlo Ambrogio Logroscino and Nicola Maffulli</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:66</dc:source>
			<dc:date>2008-05-05</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-66</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>66</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/65">
            
            <title>Motor control or graded activity exercises for chronic low back pain? A randomised controlled trial.</title>
			<description>Background:
Chronic low back pain remains a major health problem in Australia and around the world. Unfortunately the majority of treatments for this condition produce small effects because not all patients respond to each treatment. It appears that only 25-50% of patients respond to exercise. The two most popular types of exercise for low back pain are graded activity and motor control exercises. At present however, there are no guidelines to help clinicians select the best treatment for a patient. As a result, time and money is wasted on treatments which ultimately fail to help the patient. 
Methods:
This paper describes the protocol of a randomised clinical trial comparing the effects of motor control exercises with a graded activity program in the treatment of chronic non specific low back pain. Further analysis will identify clinical features that may predict a patientas response to each treatment. One hundred and seventy two participants will be randomly allocated to receive either a program of motor control exercises or graded activity. Measures of outcomes will be obtained at 2, 6 and 12 months after randomisation. The primary outcomes are: pain (average pain intensity over the last week) and function (patient-specific functional scale) at 2 and 6 months. Potential treatment effect modifiers will be measured at baseline.DiscussionThis trial will not only evaluate which exercise approach is more effective in general for patients will chronic low back pain, but will also determine which exercise approach is best for an individual patient. </description>
			<link>http://www.biomedcentral.com/1471-2474/9/65</link>
			
			 	<dc:creator>Luciana G Macedo, Jane Latimer, Christopher G Maher, Paul W Hodges, Michael Nicholas, Lois Tonkin, James H McAuley and Ryan Stafford</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:65</dc:source>
			<dc:date>2008-05-05</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-65</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>65</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/64">
            
            <title>The relative timing of VMO and VL in the aetiology of anterior knee pain: a systematic review and meta-analysis.</title>
			<description>Background:
Anterior knee pain (AKP) is a common musculoskeletal complaint. It has been suggested that one factor that may contribute to the presence of AKP is a delay in the recruitment of the vastus medialis oblique muscle (VMO) relative to the vastus lateralis muscle (VL). There is however little consensus within the literature regarding the existence or nature of any such delay in the recruitment of the VMO within the AKP population. The purpose of this systematic review and meta-analysis was to examine the relative timing of onset of the VMO and VL in those with AKP in comparison to the asymptomatic population.
Methods:
The bibliographic databases AMED, British Nursing Index, CINAHL, EMBASE, Ovid Medline, PEDro, Pubmed and the Cochrane Library were searched for studies comparing the timing of EMG onset of the VMO and VL in those with AKP versus the asymptomatic population. Studies fulfilling the inclusion criteria were independently assessed. Heterogeneity across the studies was measured. A meta-analysis of results was completed for those studies where adequate data was supplied. Where comparable methodologies had been used, results were pooled and analysed.
Results:
Fourteen studies met the inclusion criteria; one prospective and thirteen observational case control. Eleven compared VMO and VL EMG onset times during voluntary active tasks while four investigated reflex response times. All used convenience sampling and did not state blinding of the assessor. Study methodologies/testing and assessment procedures varied and there was considerable heterogeneity within individual samples. Whilst a trend was identified towards a delay in onset of VMO relative to the VL in the AKP population during both voluntary active tasks and reflex activity, a substantial degree of heterogeneity across the pooled studies was identified (I2 = 69.9-93.4%, p&lt;0.01).
Conclusions:
Findings are subject to substantial and unexplained heterogeneity. A trend was demonstrated towards a delayed onset of VMO relative to VL in those with AKP in comparison to those without. However not all AKP patients demonstrate a VMO-VL dysfunction, and this is compounded by normal physiological variability in the healthy population. The clinical and therapeutic significance is therefore difficult to assess.</description>
			<link>http://www.biomedcentral.com/1471-2474/9/64</link>
			
			 	<dc:creator>Rachel Chester, Toby O Smith, David Sweeting, John Dixon, Sarah Wood and Fujian Song</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:64</dc:source>
			<dc:date>2008-05-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-64</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>64</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/63">
            
            <title>Fatigue in osteoarthritis: a qualitative study</title>
			<description>Background:
Fatigue is recognized as a disabling symptom in many chronic conditions including rheumatic disorders such as rheumatoid arthritis (RA) and lupus. Fatigue in osteoarthritis (OA) is not routinely evaluated and has only been considered in a very limited number of studies. To date, these studies have focused primarily on patients with OA under rheumatological care, which represent the minority of people living with OA. The purpose of this study was to increase our understanding of the fatigue experience in people living with OA.
Methods:
In 2004, 8 focus groups were conducted with 28 men and 18 women (mean age 72.3) with symptomatic hip or knee OA recruited from a population-based cohort. Participants completed a self-administered questionnaire, which included demographics, measures of OA severity (WOMAC), depression (CES-D) and fatigue (FACIT). Sessions were audio taped and transcribed verbatim. Two researchers independently reviewed the transcripts to identify themes. Findings were compared and consensus reached.
Results:
Mean pain, disability, depression and fatigue scores were 8.7/20, 27.8/68, 15.4/60, and 30.9/52, respectively. Participants described their fatigue as exhaustion, being tired and 'coming up against a brick wall'. Participants generally perceived fatigue as different from sleepiness and distinguished physical from mental fatigue. Factors believed to increase fatigue included OA pain and pain medications, aging, various types of weather and poor sleep. Mental health was identified as both affecting fatigue and being affected by fatigue. Participants described fatigue as impacting physical function, and their ability to participate in social activities and to do household chores. Rest, exercise, and avoiding or getting assistance with activities were cited as ways of coping. Participants generally did not discuss their fatigue with anyone except their spouses.
Conclusions:
Participants with OA described experiencing notable amounts of fatigue and indicated that it had a substantial impact on their lives. Further research is required to better understand the role of fatigue in OA in order to identify strategies to reduce its impact. </description>
			<link>http://www.biomedcentral.com/1471-2474/9/63</link>
			
			 	<dc:creator>J. Denise Power, Elizabeth M Badley, Melissa R French, Angela J Wall and Gillian A Hawker</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:63</dc:source>
			<dc:date>2008-05-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-63</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>63</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/62">
            
            <title>Splinting after contracture release for Dupuytren's contracture (SCoRD): protocol of a pragmatic, multi-centre, randomized controlled trial </title>
			<description>Background:
Splinting as part of the overall post-surgical management of patients after release of Dupuytren's contracture has been widely reported, though there is variation in practice and criteria for using it. The evidence on its effectiveness is sparse, of poor quality and contradictory with studies reporting negative and positive effects.
Methods:
A multi-centre, pragmatic, randomized, controlled trial is being conducted to evaluate the effect of static night splinting for six months on hand function, range of movement, patient satisfaction and recurrence at 1 year after fasciectomy or dermofasciectomy. Using a centrally administered computer randomization system consented patients  will be allocated to one of two groups: i) splint group who will be given a static splint at approximately 10 to 14 days after surgery to be worn for 6 months at night time only as well as hand therapy;  ii) non-splint group, who will receive hand therapy only.  The primary outcome measure is the patient-reported Disabilities of the Arm, Hand and Shoulder Questionnaire (DASH). Secondary outcomes are total active flexion and extension of fingers, patient satisfaction and recurrence of contracture. Outcome measures will be collected prior to surgery, 3 months, 6 months and 1 year after surgery.  Using the DASH as the primary outcome measure, where a difference of 15 points is considered to be a clinically important difference a total of 51 patients will be needed in each group for a power of 90%. An intention-to-treat analysis will be used. DiscussionThis pragmatic randomized controlled trial will provide much needed evidence on the clinical effectiveness of post-operative night splinting in patients who have undergone fasciectomy or dermofasciectomy for Dupuytren's contracture of the hand.
Trial Registration: Current Controlled Trials ISRCTN 57079614</description>
			<link>http://www.biomedcentral.com/1471-2474/9/62</link>
			
			 	<dc:creator>Christina Jerosch-Herold, Lee Shepstone, Adrian J Chojnowski and Debbie Larson</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:62</dc:source>
			<dc:date>2008-04-30</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-62</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>62</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/61">
            
            <title>Comparison of two self-reported measures of physical work demands in hospital personnel: a cross-sectional study</title>
			<description>Background:
Low back pain (LBP) is a frequent health complaint among health care personnel. Several work tasks and working postures are associated with an increased risk of LBP. The aim of this study was to compare two self-reported measures of physical demands and their association with LBP (the daily number of patient handling tasks and Hollmann's physical load index).
Methods:
A questionnaire was distributed to 535 hospital employees in a psychiatric and an orthopedic ward in a Danish hospital. Of these 411 (77%) filled in and returned the questionnaire. Only the 373 respondents who had non-missing values on both measures of physical demands were included in the analyses. The distribution of physical demands in different job groups and wards are presented, variance analysis models were employed, and logistic regression analysis was used to analyze the association between measures of physical demands and LBP.
Results:
In combination, hospital ward and job category explained 56.6% and 23.3% of the variance in the self-reported physical demands measured as the daily number of patient handling tasks and as the score on the physical load index, respectively. When comparing the 6% with the highest exposure the prevalence odds ratio (POR) for LBP was 5.38 (95% CI 2.03-14.29) in the group performing more than 10 patient handling tasks per day and 2.29 (95% CI 0.93-5.66) in the group with the highest score on the physical load index.
Conclusions:
In specialized hospital wards the daily number of patient handling tasks seems to be a more feasible measure of exposure when assessing the risk of LBP compared to more advanced measures of physical load on the lower lumbar spine.</description>
			<link>http://www.biomedcentral.com/1471-2474/9/61</link>
			
			 	<dc:creator>Kirsten Nabe-Nielsen, Nils Fallentin, Karl B Christensen, Jette N Jensen and Finn Diderichsen</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:61</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-61</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>61</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/60">
            
            <title>Effectiveness of prolonged use of continuous passive motion (CPM), as an adjunct to physiotherapy, after total knee arthroplasty.  </title>
			<description>Background:
Adequate and intensive rehabilitation is an important requirement for successful total knee arthroplasty. The primary focus of early rehabilitation is ambulation and regaining range of motion in the knee.
Although research suggests that Continuous Passive Motion (CPM) should be implemented in the first rehabilitation phase after surgery, there is substantial debate about the duration of each session and the total period of CPM application. A Cochrane review on this topic concluded that short-term use of CPM leads to greater short-term range of motion. It also suggested, however, that future research should concentrate on the treatment period during which CPM should be administered.
Methods:
In a randomised controlled trial we investigated the effectiveness of prolonged CPM use in the home situation as an adjunct to standardised PT. Experimental treatment was compared with standardised physiotherapy (PT) in patients with osteoarthritis (OA) of the knee undergoing Total Knee Arthroplasty (TKA). Efficacy was assessed in terms of faster improvements in range of motion (RoM) and functional recovery, measured at the end of the active treatment period, 17 days after surgery. 
Sixty patients with knee osteoarthritis undergoing TKA and experiencing early postoperative flexion impairment (less than 80degrees of knee RoM at the time of discharge) were randomised over two treatment groups. The experimental group received CPM + PT for 17 consecutive days after surgery, whereas the usual care group received the same treatment during the in-hospital phase (i.e. about four days), followed by PT alone (usual care) in the first two weeks after hospital discharge.
From 18 days to three months after surgery, both groups received standardised PT. The primary focus of rehabilitation was functional recovery (e.g. ambulation) and regaining RoM in the knee. 
Results:
Prolonged use of CPM improved short-term RoM in patients with limited RoM at the time of discharge after total knee arthroplasty when added to a semi-standard PT programme. Assessment at 6 weeks and three months after surgery found no long-term effects of this intervention Neither did we detect functional benefits of the improved RoM at any of the outcome assessments.  
Conclusion:
Although results indicate that prolonged CPM use has a short-term effect on RoM, routine use of prolonged CPM in patients with limited RoM at hospital discharge should be reconsidered, since neither long-term effects nor transfer to better functional performance was detected.</description>
			<link>http://www.biomedcentral.com/1471-2474/9/60</link>
			
			 	<dc:creator>Ton AF Lenssen, Mike JA van Steyn, Yvonne HF Crijns, Eddie MH Waltje, George M Roox, Ruud JT Geesink, Piet A van den Brandt and Rob A de Bie</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:60</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-60</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>60</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/59">
            
            <title>Effectiveness of accelerated perioperative care and rehabilitation intervention compared to current intervention after hip and knee arthroplasty

A before-after trial of 247 patients with a 3-month follow-up
</title>
			<description>Background:
In Denmark, approximately 12,000 hip and knee arthroplasties were performed in 2006, and the hospital costs were close to US$ 110,000,000. In a randomized clinical trial, we have recently demonstrated the efficacy of accelerated perioperative care and rehabilitation intervention after hip and knee arthroplasty compared to current intervention under ideal circumstances. We do not, however, know whether these results could be reached under usual circumstances of healthcare practice. We therefore investigated whether length of stay after implementation of accelerated perioperative care and rehabilitation after hip and knee arthroplasty could be reduced in a normal healthcare setting, and how the achieved results matched those observed during the randomized clinical trial.
Methods:
An effectiveness study as a before-after trial was undertaken in which all elective primary total hip and total knee arthroplasty patients were divided into a before-implementation group receiving the current perioperative procedure, and an after-implementation group receiving the new accelerated perioperative care and rehabilitation procedures as provided by a new multi-disciplinary organization. We used the Breakthrough Series Collaborative Model for implementation. The primary outcome measure was in hospital length of stay (LOS), and the secondary outcome measure was adverse effects within 3 months postoperatively.
Results:
We included a total of 247 patients. Mean LOS was significantly (P &lt; 0.001) reduced by 4.4 (95% CI 3.8-5.0) days after implementation of the accelerated intervention, from 8.8 (SD 3.0) days before implementation to 4.3 (SD 1.8) days after implementation. No significant differences in adverse effects were observed. LOS in this effectiveness study was significantly lower than LOS reported in the efficacy study.
Conclusions:
Accelerated perioperative care and rehabilitation intervention after hip and knee arthroplasty was successfully and effectively implemented. Results obtained during usual hospital circumstances matched the results achieved under ideal circumstances in this group of patients.</description>
			<link>http://www.biomedcentral.com/1471-2474/9/59</link>
			
			 	<dc:creator>Kristian Larsen, Karen E Hvass, Torben B Hansen, Per B Thomsen and Kjeld Soballe</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:59</dc:source>
			<dc:date>2008-04-28</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-59</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>59</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/58">
            
            <title>A randomised clinical trial of subgrouping and targeted treatment for low back pain compared with best current care. The STarT Back Trial Study Protocol</title>
			<description>Background:
Back pain is a major health problem and many sufferers develop persistent symptoms. Detecting relevant subgroups of patients with non-specific low back pain has been highlighted as a priority area for research, as this could enable better secondary prevention through the targeting of prognostic indicators for persistent, disabling symptoms. We plan to conduct a randomised controlled trial to establish whether subgrouping using a novel tool, combined with targeted treatment, is better than best current care at reducing long-term disability from low back pain.
Methods:
We will recruit 800 participants aged 18 years and over with non-specific low back pain from 8-10 GP practices within two Primary Care Trusts in Staffordshire, England. Our primary outcome measures are low back pain disability and catastrophising. Secondary outcomes include back pain intensity, global change, leg pain, fear avoidance, anxiety, depression, illness perceptions, patient satisfaction, overall health status and cost-effectiveness. Data will be collected before randomisation, and 4 and 12 months later. Participants are randomised to receive either newly developed interventions, delivered by trained physiotherapists and targeted according to subgroups defined by tool scores, or best current care. DiscussionThis paper presents detail on the rationale, design, methods and operational aspects of the trial.
Trial registration: Current Controlled Trials ISRCTN37113406.</description>
			<link>http://www.biomedcentral.com/1471-2474/9/58</link>
			
			 	<dc:creator>Elaine M Hay, Kate M Dunn, Jonathan C Hill, Martyn Lewis, Elizabeth E Mason, Kika Konstantinou, Gail Sowden, Simon Somerville, Kanchan Vohora, David Whitehurst and Chris J Main</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:58</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-58</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>58</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/57">
            
            <title>Bracing Patients with Idiopathic Scoliosis: Design of the Dutch Randomized Controlled Treatment Trial</title>
			<description>Background:
The effectiveness of bracing patients with IS has not yet been convincingly established due to a lack of RCTs. Some authors suggest that their results confirm that bracing is effective; others conclude that the effectiveness of bracing is doubtful or recommend a RCT. The aim of this study was to establish whether bracing patients with idiopathic scoliosis (IS) in an early stage will result in at least 5 degrees less mean progression of the curvature compared to the control group after two years of follow-up. 
Methods:
A randomized controlled trial was designed. Eligible patients are girls and boys in the age group 8-15 years whose diagnosis of IS has been established by an orthopedic surgeon, who have not yet been treated by bracing or surgery, and for whom further growth of physical height is still expected based on medical examination and maturation characteristics (Risser a 2). The Cobb angle of the eligible patient should either be minimally 22 and maximally 29 degrees with established progression of more than 5 degrees, or should be minimally 30 and maximally 35 degrees; established progression for the latter is not necessary. A total of 100 patients will be included in this trial. The intervention group will be treated with full-time Boston brace wear; the control group will not be braced. Every four months, each patient will have a physical and an X-ray examination. The main outcomes will be the Cobb angle two years after inclusion and health-related quality of life.DiscussionThe results of this trial will be of great importance for the discussion on early treatment for scoliosis. Furthermore, the result will also be important for screening for scoliosis policies.   </description>
			<link>http://www.biomedcentral.com/1471-2474/9/57</link>
			
			 	<dc:creator>Eveline M Bunge, Harry J de Koning and The Brace trial group</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:57</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-57</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>57</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/56">
            
            <title>Efficacy and safety of a subacromial continuous ropivacaine infusion for post-operative pain management following arthroscopic rotator cuff surgery: a protocol for a randomised double-blind placebo- controlled trial.</title>
			<description>Background:
Major shoulder surgery often results in severe post-operative pain and a variety of interventions have been developed in an attempt to address this. The continuous slow infusion of a local anaesthetic directly into the operative site has recently gained popularity but it is expensive and as yet there is little conclusive evidence that it provides additional benefits over other methods of post-operative pain management.
Methods:
This will be a randomised, placebo-controlled trial involving 158 participants. Following diagnostic arthroscopy, all participants will undergo either arthroscopic subacromial decompression with or without rotator cuff repair, by a single surgeon. Participants, the surgeon, nurses caring for the patients and outcome assessors will be blinded to treatment allocation. A pre-incision bolus injection of 10mls of ropivacaine 1% into the shoulder and an intra-operative intravenous bolus of parecoxib 40mg.will be given. Using concealed allocation participants will be randomly assigned to active treatment (local anaesthetic ropivacaine 0.75%) or placebo (normal saline) administered continuously into the subacromial space by an elastometric pump at 5 mls per hour post-operatively. Patient controlled opioid analgesia and oral analgesics will be available for breakthrough pain. Outcome assessment will be at 15, 30 and 60 minutes, 2, 4, 8, 12, 18 and 24 hours, and 2 or 4 months for decompression or decompression plus repair respectively.
The primary end point will be the average pain at rest over the first 12-hour post-operative period, on a verbal analogue pain score from 0 to 10.. Secondary end points will be average pain at rest over the second 12-hour post-operative period, maximal pain at rest over the first and second 12-hour periods, amount of rescue medication used, length of inpatient time following decompression, and decompression plus repair, and the incidence of post-operative adhesive capsulitis up to 2 or 4 months following decompression or decompression plus repair respectively.DiscussionThe results of this trial will contribute to evidence-based recommendations for the effectiveness of pain management modalities following arthroscopic rotator cuff surgery. If the local anaesthetic pain-buster provides no additional benefits over placebo then valuable resources can be put to better use in other ways. </description>
			<link>http://www.biomedcentral.com/1471-2474/9/56</link>
			
			 	<dc:creator>Jennifer A Coghlan, Andrew Forbes, Simon N Bell and Rachelle Buchbinder</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:56</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-56</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>56</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2474/9/55">
            
            <title>Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery</title>
			<description>Background:
Cutpoints (CPs) for mild, moderate and severe pain are established and used primarily in cancer pain. In this study, we wanted to determine the optimal CPs for mild, moderate, and severe pain in joint replacement surgery candidates with osteoarthritis (OA) of the hip or knee, and to validate the different CPs.
Methods:
Patients (n=353) completed the Brief Pain Inventory (BPI), the WOMAC Arthritis Index, and the SF-36 health status measure. Optimal CPs for categorizing average pain with three severity levels were derived using multivariate analysis of variance, using different CP sets for average pain as the independent variable and seven interference items from the BPI as the dependent variable. To validate the CPs, we assessed if patients in the three pain severity groups differed in pain as assessed with WOMAC and SF-36, and if BPI average pain with the optimal CPs resulted in higher correlation with pain dimensions of the WOMAC and SF-36 than other CPs.
Results:
The optimal CPs on the 0-10 point BPI scale were CP (4,6) among hip patients and CP (4,7) among  knee patients. The resulting pain severity groups differed in pain, as assessed with other scales than those used to derive the CPs. The optimal CPs had the highest association of average pain with WOMAC pain scores.  
Conclusion:
CPs for pain severity differed somewhat for patients with OA of the hip and knee. The association of BPI average pain scores categorized according to the optimal CPs with WOMAC pain scores supports the validity of the derived optimal CPs. </description>
			<link>http://www.biomedcentral.com/1471-2474/9/55</link>
			
			 	<dc:creator>Heidi Kapstad, Berit R. Hanestad, Norvald Langeland, Tone Rustoen and Knut Stavem</dc:creator>
			
			<dc:source>BMC Musculoskeletal Disorders 2008, 9:55</dc:source>
			<dc:date>2008-04-21</dc:date>
			<dc:identifier>doi:10.1186/1471-2474-9-55</dc:identifier>
			
			
							
					<prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
					
			
							
					<prism:issn>1471-2474</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>55</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-21</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
